GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (CHIX:CNWKd) » Definitions » NonCurrent Deferred Liabilities

Codon AG (CHIX:CNWKD) NonCurrent Deferred Liabilities : €0.00 Mil (As of Jun. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Codon AG NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Codon AG's non-current deferred liabilities for the quarter that ended in Jun. 2022 was €0.00 Mil.

Codon AG NonCurrent Deferred Liabilities Historical Data

The historical data trend for Codon AG's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codon AG NonCurrent Deferred Liabilities Chart

Codon AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Codon AG Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Codon AG NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Codon AG's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Codon AG (CHIX:CNWKD) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Warthestrasse 21, Teltow, DEU, 14513
Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.

Codon AG (CHIX:CNWKD) Headlines

No Headlines